This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Christopher Stock, PharmD
Lansing, Mich

Arch Intern Med. 1988;148(1):241-245.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—In a recent issue of the ARCHIVES,¹ Baumgartner and Rowen reported that clonidine was as effective as chlordiazepoxide in relieving signs and symptoms of alcohol withdrawal. The major goals of treating patients who are experiencing alcohol withdrawal should include (1) reducing patient discomfort, (2) alleviating dangerous signs of withdrawal, (3) preventing morbid sequellae, and (4) preparing the alcoholic to accept treatment for his/her disease. Though Baumgartner and Rowen suggest that "clonidine should be further investigated and seriously considered in the pharmacotherapy of acute alcohol withdrawal syndrome," a thorough examination of these goals may reveal that clonidine does not yet deserve this acclaim.

There has been no agreement among investigators as to how to objectively and standardly assess reduction in patient discomfort during trials of therapy for alcohol withdrawal syndromes.² None of the studies testing the effectiveness of clonidine have used the same outcome measures. These . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?